NCT01175551

Brief Summary

Racism and health care system distrust are potent stressors and may be associated with preterm birth (PTB). Additionally, cervical shortening is a common pathway leading to PTB. This study is enrolling a prospective cohort of pregnant women. The study assesses racial discrimination, health care system distrust, and cervical change using 2 questionnaires, exam, and protein levels in cervical vaginal fluid and maternal serum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,207

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2009

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 5, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

January 7, 2014

Status Verified

January 1, 2014

Enrollment Period

2 years

First QC Date

July 29, 2010

Last Update Submit

January 6, 2014

Conditions

Keywords

Preterm BirthCervixCervical ShorteningCervical remodelingPTB

Outcome Measures

Primary Outcomes (1)

  • Preterm birth (delivery at less than 37 weeks)

    16-37 weeks from enrollment

    up to 42 weeks

Secondary Outcomes (1)

  • spontaneous Preterm Birth at less than 37 weeks and less than 34 weeks, small for gestational age (less than the 10% birth weight for gestational age as determined by the Alexander curve), preeclampsia and a composite of neonatal outcomes

    up to 42 weeks

Study Arms (2)

Group 1

women screened at Penn OB/GYN Associates or Helen O. Dickens Center with a documented singleton pregnancy less than 18 weeks gestational age

Group 2

Nulliparous pregnant women (no previous pregnancy greater than 15 weeks) screened at Penn OB/GYN Associates or Helen O. Dickens Center less than 18 weeks gestational age

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pregnant women screened at Penn OB/GYN Associates or Helen O. Dickens Center at less than 18 weeks gestational age with a documented singleton pregnancy who agree to participate in the study (group 1); Nulliparous women (no previous pregnancy greater than 15 weeks)less than 18 weeks gestational age (group 2)

You may qualify if:

  • All pregnant women screened at \< 18 weeks with a documented singleton pregnancy, who agree to participate in the study (group 1). A subset of Nulliparous women (no previous pregnancy 15 weeks)(group 2) will be assessed.
  • Women of all races and age will be included.

You may not qualify if:

  • Women with a multi-fetal pregnancy, current use of systemic steroids or immunosuppressive therapy or enrollment for prenatal care after 24 weeks.
  • Women with a prior documented history of Leep or Conization will be excluded.
  • Any known Mullerian anomalies such as septate uterus, bicornuate or unicornuate uterus will be excluded given that these are high risk groups for preterm delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Helen O. Dickens Center for Women

Philadelphia, Pennsylvania, 19104, United States

Location

Penn OB/GYN Associates

Philadelphia, Pennsylvania, 19104, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

maternal serum, maternal cervical vaginal fluid

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Michal A Elovitz, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Sindhu Srinivas, MD, MSCE

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Director, Maternal and Child Health Research Program, Department of Obstetrics and Gynecology

Study Record Dates

First Submitted

July 29, 2010

First Posted

August 5, 2010

Study Start

November 1, 2009

Primary Completion

November 1, 2011

Study Completion

May 1, 2012

Last Updated

January 7, 2014

Record last verified: 2014-01

Locations